Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the incorporation by reference in this Registration Statement of Conduit Pharmaceuticals Inc. on Form S-8 of our report dated April 16, 2024, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Conduit Pharmaceuticals Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 appearing in the Annual Report on Form 10-K of Conduit Pharmaceuticals Inc. for the year ended December 31, 2023.
/s/ Marcum llp
Marcum llp
Morristown, NJ
February 6, 2025
